Your search results are below. For a different search, enter another term below and click on the "Search" button:
-
381. Meet the at-home colon cancer test detecting polyps with 90% accuracy
Solvd Health is developing a colorectal neoplasia test that detects precancerous polyps with 90 percent accuracy. The FDA granted the test Breakthrough Device designation in September 2019, and CMS ...24 February 2021 -
382. AI in GI: 7 updates since 2020
... patterns related to colorectal cancer progression, according to a Sept. 1 report. 7. A Chinese study examined the effect AI had on colonoscopy detection and found real-time quality systems improved ...16 February 2021 -
383. Risk stratification tools don't boost CRC screening rates, study finds
Providers have attempted to improve colorectal cancer screening rates by using risk stratification, but recent research debunked the effectiveness of the strategy, according to a study published in February ...11 February 2021 -
384. February 2021 Issue of Becker's ASC Review
... Patients with a family history of colorectal cancer that had a negative screening colonoscopy may be able to wait 10 years for their next exam, according to a study submitted to 2020 Digestive Disease ...10 February 2021 -
385. 6 recent updates on colonoscopy
... procedure. Read more. 2. Delaying colonoscopy after a positive stool test increases CRC rates. Patients must confirm a positive stool-based colorectal cancer screening test with a colonoscopy, and delaying ...05 February 2021 -
386. 1st risk factors for early-onset CRC identified, study says
Family history of colorectal cancer, hyperlipidemia, obesity and alcohol consumption could all be risk factors behind developing early-onset colorectal cancer, according to a Jan. 28 study published in ...04 February 2021 -
387. Looking back at 2020: A year like no other for ASCs
... beneficiary cost sharing for colorectal cancer to be phased out Near the end of 2020, the "Consolidated Appropriations Act, 2021" was signed into law. The law brings good news for gastroenterology patients, ...04 February 2021 -
388. Delaying colonoscopy after positive stool-based screening test increases CRC rates, study finds
Patients must confirm a positive stool-based colorectal cancer screening test with a colonoscopy, and delaying that follow-up colonoscopy has led to increased CRC rates, according to a study published ...03 February 2021 -
389. Gastro Health's latest acquisition, why United Digestive is taking it slow and more — 5 GI industry notes
... CancerLink to screen uninsured and underinsured Kentucky residents for colorectal cancer. 4. Atlanta-based United Digestive's CEO and chief strategy officer told Becker's ASC Review about their focus on ...03 February 2021 -
390. Kentucky Mercy Health affiliate joins state's colon cancer screening program
Mercy Health-Lourdes Hospital in Paducah, Ky., partnered with Kentucky CancerLink to screen uninsured and underinsured Kentucky residents for colorectal cancer, The Paducah Sun reported Jan. 29. The ...01 February 2021 -
391. What GI practices can learn from the pandemic
... rely on colorectal cancer screening and surveillance colonoscopies for nearly 80 percent of their revenue. More importantly, reduced patient volumes meant some key staff lost their jobs and critical patient ...01 February 2021 -
392. 10,000+ deaths likely result of pandemic screening delays, more reports predict
... Jan. 28. The researchers examined screening rates for colorectal cancer and breast cancer during the COVID-19 pandemic. Richard Bold, MD, physician-in-charge at UC Davis Comprehensive Cancer Center, ...29 January 2021 -
393. The ASC market's revenues, Dr. Farid Namin's PPE manufacturer and more — 4 GI industry notes
... procurement obstacles early in the pandemic. 4. The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test. More ...27 January 2021 -
394. Trump pardons CEO of controversial pain practice, Optum's plans to grows & more — 8 ASC industry notes
... a Jan. 20 earnings call. Read more. The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test, the company announced ...26 January 2021 -
395. At-home options boost CRC screening rates, study finds
A study of Kaiser Permanente members in Southern California found that offering patients to self-order a colorectal cancer screening test online increases rates of test completion, according to a Jan. ...21 January 2021 -
396. CMS declines to reimburse for 1st FDA-approved blood-based CRC screening test
The FDA declined to extend National Coverage Determination to Epigenomics AG for its Epi proColon, a blood-based colorectal cancer screening test, the company announced Jan. 21. Epigenomics AG will ...21 January 2021 -
397. Liquid biopsy test detected patients at risk for CRC relapse
A liquid biopsy test that detects circulating tumor DNA identified patients likely to redevelop colorectal cancer after having undergone surgery to remove tumors, Medpage Today reported Jan. 17. Researchers ...19 January 2021 -
398. Exact Sciences' $58B bet on diagnostic screening & 4 other updates from the company's busy week
... in three diagnostic screening markets: colorectal cancer screening, multi-cancer screening, and minimal residual disease and recurrence monitoring. The three markets represent a combined $58 billion market. ...15 January 2021 -
399. CRC blood tests, partnerships and more — 4 GI industry notes
... novel multiomics blood test for colorectal cancer detected advanced adenomas with a 41 percent sensitivity at 90 percent specificity, according to results from its Ai-Emerge study. A developer is building ...13 January 2021 -
400. New blood test detects CRC advanced adenomas, study says
Freenome's novel multiomics blood test for colorectal cancer detected advanced adenomas with a 41 percent sensitivity at 90 percent specificity, according to results from its Ai-Emerge study. Researchers ...12 January 2021